An observational study in Central Venous Catheter Thrombosis, Critical Illness and Ultrasonography, sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. Completed at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-10-24.
Sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University · Observational
The central venous catheters (CVC) related thrombosis is an issue of importance to ICU clinicians.This study conducts the daily ultrasound-screening for CVC-related thrombosis (DUCT).Its aim is to evaluate the characteristic and regularity of the central venous catheters (CVC) related thrombosis in ICU patients, and optimize the screening program of CVC-related thrombosis.
We conduct an observational prospective multicenter study.The patients come from the ICUs of Zhejiang province.
Exclusion Criteria:
The patients who have a central venous catheterization conduct the daily ultrasound-screening for CVC-related Thrombosis (DUCT).
Device: ultrasound-screening
Daily ultrasound-screening for CVC-related thrombosis (DUCT) by compression ultrasound and color doppler ultrasound.
the incidence rate of central venous catheters related thrombosis (CRT)
the percentage of patients who have CRT in all patients included.
Time frame: the assessment time will be from the time patients admitted in ICU to the time leaving ICU, less than 6 months.
the time when the central venous catheters related thrombosis (CRT) occured
which day the CRT is found after central venous catheter.
Time frame: the assessment time will be from the time patients admitted in ICU to the time leaving ICU, less than 6 months.
Plan to share: Undecided
This study is completed, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Second Affiliated Hospital, School of Medicine, Zhejiang University